Advance Praise for The CEO Test:
"Adam Bryant and Kevin Sharer make a brilliant, inspired team. Bryant brings a vast mental database of more than six hundred structured conversations with elite leaders, combined with a gift for weaving smart, lucid prose. Sharer brings decades of strategic experience, including as CEO of Amgen, which became one of the world's first truly great and enduring biotechnology companies. I just love the idea of bringing Bryant's incisive insight together with Sharer's practical wisdom to address the vexing challenges of leadership." — Jim Collins, author, Good to Great; coauthor, Built to Last and Beyond Entrepreneurship 2.0
"Sharer and Bryant mine insights from hundreds of CEOs to identify universal lessons that will help leaders at all levels become more effective. They steer clear of the truisms and platitudes that are all too common in leadership books and instead rely on their genuine journalistic curiosity and a gift for pattern-spotting—along with memorable stories—to bring the essential challenges of leadership to life." — Meredith Kopit Levien, CEO, The New York Times Company
"The CEO Test provides an honest, candid approach to the countless issues that leaders at all levels might face. It's a must-read, whether you’re in the CEO seat today or aspire to be in it in the future." — Stephen J. Squeri, Chairman and CEO, American Express
"Bryant and Sharer have captured the essence of successful leadership. Their examples are equally applicable to companies large and small and to leaders of all functions and levels, from the C-suite to entry level." — Ellen J. Kullman, former Chairman and CEO, DuPont; CEO, Carbon
"As two astute observers and successful practitioners of the art themselves, Bryant and Sharer have crafted a magnificently insightful guide to great leadership. The CEO Test should be required reading, not just for CEOs but for leaders at all levels who are ready to raise their game." — Ronald D. Sugar, former Chairman and CEO, Northrop Grumman Corporation; board director, Apple, Amgen, Chevron, and Uber